Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Condition:   Head and Neck Cancer Intervention:   Drug: TAK-981 Sponsors:   Presage Biosciences;   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials